» Articles » PMID: 21325349

Iron and Vascular Calcification. Is There a Link?

Overview
Date 2011 Feb 18
PMID 21325349
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Iron deficiency is frequently seen in patients with end-stage renal disease, particularly in those treated by dialysis, this is because of an impairment in gastrointestinal absorption and ongoing blood losses or alternatively, due to an impaired capacity to mobilize iron from its stores, called functional iron deficiency. Therefore, these patients may require intravenous iron to sustain adequate treatment with erythropoietin-stimulating agents. Aside from this, they are also prone to vascular calcification, which has been reported a major contributing factor in the development of cardiovascular disease and the increased mortality associated herewith. Several factors and mechanisms underlying the development of vascular calcification in chronic kidney diseased patients have been put forward during recent years. In view of the ability of iron to exert direct toxic effects and to induce oxidative stress on the one hand versus its essential role in various cellular processes on the other hand, the possible role of iron in the development of vascular calcification should be considered.

Citing Articles

Iron and bones: effects of iron overload, deficiency and anemia treatments on bone.

von Brackel F, Oheim R JBMR Plus. 2024; 8(8):ziae064.

PMID: 38957399 PMC: 11215550. DOI: 10.1093/jbmrpl/ziae064.


Effect of iron administration on the aortic iron content and vascular calcification in phosphorus-loaded chronic kidney disease rats.

Nakanishi M, Goto A, Iwasaki T, Nakanishi T, Kuma A, Nanami M BMC Nephrol. 2023; 24(1):373.

PMID: 38102596 PMC: 10725022. DOI: 10.1186/s12882-023-03426-5.


Vascular calcification: Molecular mechanisms and therapeutic interventions.

Pan W, Jie W, Huang H MedComm (2020). 2023; 4(1):e200.

PMID: 36620697 PMC: 9811665. DOI: 10.1002/mco2.200.


The Role of Iron in Calciphylaxis-A Current Review.

Wickens O, Rengarajan S, Chinnadurai R, Ford I, Macdougall I, Kalra P J Clin Med. 2022; 11(19).

PMID: 36233647 PMC: 9570530. DOI: 10.3390/jcm11195779.


Potential intervention target of atherosclerosis: Ferroptosis (Review).

Li J, Xu L, Zuo Y, Chang X, Chi H Mol Med Rep. 2022; 26(5).

PMID: 36148885 PMC: 9551408. DOI: 10.3892/mmr.2022.12859.